The U.S. FDA granted Neuronetics Inc. clearance for use of its Neurostar advanced therapy as an adjunctive treatment of major depressive disorder in patients aged 15 to 21, making it the first transcranial magnetic stimulation treatment (TMS) cleared for this age group, the company said.
FDA cleared 28 spine-related devices with 510(k) approval in October, including Vital Spinal Fixation System, Acro Composites Interbody System, Zeus Spinal Syst
Medtronic, a medical device company, has secured 510(k) clearance from the FDA for 16 new devices since the beginning of 2023, including several spinal and orth